March 8, 2022

Action Alert! Support Progress in the Fight to End Duchenne

Urge your House and Senate Members to Support the FY 2023 Duchenne Funding Request & BENEFIT Act Today, during PPMD’s 2022 Advocacy Conference: Virtual Fly-In, over 260 advocates will be participating in 240+ virtual meetings…

Learn More

March 4, 2022

Race Athlete Spotlight: Austin Hogan

This year, Austin Hogan ran the Houston Half Marathon as part of the Race to End Duchenne team. Meet Austin Why did you choose to join the Race to End Duchenne team? Our family friend…

Learn More

February 22, 2022

PPMD’s Power of Us Summit Series: Caregiver registration is now open!

The Power of Us Summit Series — Registration for Parents, Grandparents & Caregivers Is Now Open! April 28-30, 2022 | Atlanta, GA The Power of Us is stronger than any of us alone. Over the…

Learn More

February 11, 2022

Connect with PPMD’s Care Team

At PPMD, we place immense value on personal connection with the Duchenne community to provide support and partner with you on this complex journey. As our organization continues to grow, we aim to remain present,…

Learn More

February 4, 2022

WATCH: FibroGen DMD Pamrevlumab Phase 3 Clinical Studies Highlight (Webinar Recording)

FibroGen joined PPMD for a webinar on February 2, 2022. During the webinar, FibroGen discussed the clinical rationale for the use of Pamrevlumab by highlighting its Phase 2 study in non-ambulatory participants with Duchenne and…

Learn More

February 3, 2022

New Study to Understand Duchenne Patients’ and Caregivers’ Attitudes Towards Gene Therapy Launched

In a new transatlantic collaboration, Parent Project Muscular Dystrophy (PPMD) and Duchenne UK (DUK), the DMD Hub, and RTI International are conducting a study to explore attitudes towards gene therapy and gene editing from adults…

Learn More

February 1, 2022

Join PPMD’s Virtual Advocacy Conference on March 8

Want to be part of history? Want to contribute to future progress in understanding, diagnosing, and treating Duchenne? Join PPMD’s Virtual Fly-In: Tuesday, March 8, 2022 Each year, PPMD ensures that the Duchenne community is…

Learn More

January 26, 2022

Save the Date for PPMD’s Upcoming Events!

PPMD is excited to announce our 2022 schedule of educational events, including PPMD’s Annual Conference (hybrid in-person & virtual meeting), End Duchenne Tour (both in-person and virtual stops), and Advocacy Conference (virtual). New this year, PPMD will host The Power of…

Learn More

January 25, 2022

Capricor & Nippon Shinyaku Enter Partnership for Commercialization and Distribution of CAP-1002 in the U.S.

Capricor Therapeutics and Nippon Shinyaku (US subsidiary: NS Pharma) have announced that they have entered into an agreement for the exclusive commercialization and distribution in the United States of CAP-1002, Capricor’s novel cell therapy candidate…

Learn More

January 24, 2022

Thanking PPMD’s Kathi Kinnett for 20+ Years of Service to the Duchenne Community as She Retires

PPMD celebrates Kathi Kinnett, MSN, APRN, a dedicated member of our incredible Care Team for 10 years, as she announces her retirement at the end of this month. Kathi joined PPMD in 2012 after years of…

Learn More